Since the success of hGH synthesis by recombinant DNA technology (Goeddel et al., 1979) , several investigators have reported tests of methyonyl-hGH (met-hGH) for its properties and biological activities in man and animals (Olson et al., 1981; Hizuka et al., 1982; Rosenfeld et al., 1982a Rosenfeld et al., , 1982b Frigeri et al., 1982; Hintz et al., 1982) . In this paper, we have investigated the acute effect of met-hGH in eight healthy male volunteers and compared them with those of pituitary human growth hormone. We have also studied the disappearance rate of hGH after iv administration to two volunteers. of either 8IU met-hGH or pit-hGH for four days without awareness. On the 10th day after the last injection, pit-hGH or met-hGH was injected into the other group in a similar manner. The injections of hGH were given daily at 8:00am.
During the study, vital signs were checked by a physician. Blood count, urinalysis, 12-lead electrocardiogram, routine blood chemistry, and serum T3, T4 and TSH measurement were performed before and after the four daily injections of hGH. Serum somatomedin and insulin were assessed daily 24hours after the previous injection.
After the first injection, plasma hGH was determined at 0, 1, 2, 3, 4, 6, 10 and 24hours, and non-esterified fatty acid was measured at 0 and 4 hours. 
Assay methods
Plasma GH was determind by double antibody RIA, a gift from the National Pituitary Agency, NIADDK (hGH: AFP-4793B, Antibody: AFP-977201-33). Serum insulin was measured by double-antibody technique using the kit provided by Eiken Chemical Co., Ltd. (Tokyo, Japan).
Serum somatomedin was determined by the radioreceptor assay for somatomedin A described previously (Takano et al. 1976 ). Anti-hGH antibody was determined by the polyethylene glycol method (Besbuquois and Aurbach 1971 
Statistical analysis
Student's t-test and paired t-test were used for statistical analysis.
Period effect (time trend) was statistically analized according to the method described by Hills and Armitage (1979) .
Results
In the RIA, the dose-response curves for met-hGH and pit-hGH paralleled the pituitary hGH standard from the National Pituitary Agency (Fig. 1 ). In the RRAs using IM-9 cells or pregnant rabbit liver membrane, met-hGH and pit-hGH behaved in the same manner as pituitary hGH standard (data not shown).
When the ratio of radioreceptorassayable hGH to radioimmunoassayable hGH (RRA/RIA) was calculated, the ratio for met-hGH was 1.0 which was identical to the pituitary hGH standard. When met-hGH was gel filtered on Sephadex Vol. There were no significant differences between met-hGH and pit-hGH in their ability to increase serum NEFA and somatomedin A. Serum insulin concentrations did not change significantly during hGH injections. After one intravenous bolus administration of 4IU hGH to two volunteers, the serum concentrations of hGH increased rapidly and reached 236 and 348ng/ml 5 minutes after met-hGH and 278 and 308 ng/ml 5minutes after pit-hGH injection, respectively (Fig. 5) . The half lives of the two hGHs in the two volunteers did not differ greatly and the values were 16.6 and 17.7, and 16.9 and 17.2minutes, respectively, when calculated from the disappearance curve between 10 and 45minutes after hGH administrations.
Serum insulin, NEFA and blood glucose did not change significantly when they were measured at 15, 30, 60 and 120minutes after hGH administration. During the short-term administration of the two hGHs, there were no pyrogenic effects, and no significant changes in physical examination, electrocardiogram and urinalysis results.
The results of the paired t-test revealed some changes in blood count, routine blood chemistries, T4, and TSH levels, as shown in Table 1 ; however, the differences were within the normal ranges.
Anti-hGH antibody did not appear in the serum obtained before, immediately after the 4 daily injections, or 30days after the first injection of either hGH.
There is no periodic effect on the parameters which we examined in this study.
Discussion
The human growth hormone produced in E. coli has an extra methionine residue at the aminoterminal end of the mature hGH.
We studied its properties and confirmed that methionyl hGH (met-hGH) has characteristics with respect to gel filtration, RIA, and RRA indistinguishable from those of pit-hGH, which were reported by Hizuka et al. (1982) .
The short term injection of 8IU methGH did not cause any side effects such as fever, liver dysfunction, or the appearance of anti-hGH antibody. Rosenfeld et al. (1982) reported that met-hGH increased the plasma glucose and insulin levels after 16 IU daily im injections to normal volunteers.
We did not obtain similar results, probably being due to the amount of methGH used in our study, which was half of theirs. Hintz et al. (1982) reported decreases in blood urea nitrogen and cholesterol, and an increase in serum triglycerides measured 18 hours after the last of 4 daily injections. We observed similar results when blood samples were measured 24hours after the last of the 4 daily injections.
We also observed the metabolic effect of met-hGH increasing non-esterified fatty acid and somatomedin A. These effects were indistinguishable from those obtained with pit-hGH.
After im injection of hGH, the peak level seems to appear earlier with met-hGH than pit-hGH.
This result is similar to that reported by Hintz et al. (1982) .
As the disappearance rate of the two hGHs did not differ significantly, these results suggest that met-hGH absorbs faster than pit-hGH. We conclude that short-term administration of met-hGH did not show any side effects and met-hGH had a biological effect similar to that of pit-hGH. The long-term effects of met-hGH on growth in patients with growth hormone deficiency will be studied.
